Ethyl 3-bromo-7-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate, 95+%, 1g

Sodium hydroxide, min. 98%, pa, ISO, in pellets, 2.5 kg, plastic packaging.

3-(2,5-Difluorobenzoyl)-4-methylpyridine, 97.0%, 1g

4H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one, 97%, 50mg

(S)-4-ISOPROPYL-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

Ethyl 4-n-butylbenzoylformate, 96.0%, 5g

2-chloro-N-(2,5-dimethylphenyl)acetamide, 90.0%, 1g

5-Chloro-4-fluoro-2-iodoaniline, 95.0%, 1g

Phthalamic Acid>98.0%(HPLC)(T)25g

4'-Nitrobenzo-15-crown 5-Ether>99.0%(GC)5g

Thieno[3,2-d]pyrimidin-4(1H)-one>98.0%(HPLC)(T)5g

Methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate, 95%, 250mg

1-benzyl-N-[(3-methylthiophen-2-yl)methyl]piperidin-4-amine dihydrochloride, 95.0%, 2g